TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | 5 | -23 | -28 | -18 | 150 | 17 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/4/19 19:58 | 10/3/19 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | P | 80 | 17.50 | 0 | 5 | 5 | 95 | D | ||||||||||||||
6/26/14 18:48 | 6/25/14 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | P | 118 | 11.75 | 2 | 10 | 19 | 62 | D | -17 | 62 | 35 | -15 | 2 | 8 | 3 | -10 | 0 | 5 | -23 | -28 | -18 | 150 |
11/21/13 15:57 | 11/20/13 | APPA | Ap Pharma Inc /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | P | 400 | 0.4000 | 0 | 1,000 | 999% | 1,037 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |